Long-term effectiveness of an automated guideline adherence monitor for secondary prevention of acute myocardial infarction.
An automated guideline monitor for secondary prevention of acute myocardial infarction (AMI) has been favorably tested at an academic medical center using a randomized controlled trial. Subsequently, the monitor was implemented in a production mode and has been in production use for five years. Statistical process control analysis shows a generally sustainable effect of the intervention.